Table 5.
Comparison of the pharmacokinetics of irinotecan and SN-38
| TANDEM-IRI | FOLFIRI | P value | |
|---|---|---|---|
| AUC of irinotecan (hr*ng/ml) | 4327.1 ± 2919.1 | 8958.1 ± 4484.1 | N.S. |
| AUC/Dose of irinotecan | 37.8 ± 12.8 | 36.9 ± 17.0 | N.S |
| AUC of SN-38 (hr*ng/ml) | 269.9 ± 148.3 | 165.7 ± 90.3 | N.S |
| AUC/Dose of SN-38 | 3.01 ± 1.87 | 0.68 ± 0.36 | 0.009 |
| Cmax of irinotecan (hr*ng/ml) | 624.7 ± 469.7 | 1626.0 ± 264.1 | < 0.001 |
| Cmax/Dose of irinotecan | 5.4 ± 2.4 | 6.8 ± 1.2 | N.S |
| Cmax of SN-38 (hr*ng/ml) | 30.4 ± 17.1 | 18.8 ± 6.3 | N.S |
| Cmax/Dose of SN-38 | 0.32 ± 0.11 | 0.08 ± 0.03 | < 0.001 |